The Danaher subsidiary aims to meet clinician needs for flexibility with a range of test size options for its vast installed base.

In the rapidly expanding landscape of molecular diagnostics, the focus is shifting from top to bottom, with a redirection from post-pandemic respiratory testing to developments in gastrointestinal (GI ...

FRIENDSWOOD, Texas - Castle Biosciences, Inc. (NASDAQ:CSTL), known for its innovative diagnostic tests and maintaining a strong financial position with more cash than debt, announced today its intent ...